CalCs - Calendar Complications vs Kemo Pro
CalCs - Calendar Complications
Akihiro Usui
App Store
$6/mo
~$71/yr · 450 installs
VS
Kemo Pro
NumLake Tech Limited
App Store
$0/mo
~$0/yr · 9.9M installs
Revenue winner
CalCs - Calendar Complications wins
+600% vs other
Installs winner
Kemo Pro wins
+2199460% vs other
MAU winner
Kemo Pro wins
+2199460% vs other
Rating winner
Kemo Pro wins
+1% vs other
Why CalCs - Calendar Complications is winning
Top 1 reasons - backed by the public App Store / Play Store numbers.
- CalCs - Calendar Complications earns roughly 6× more per month than Kemo Pro - $6 vs $0.
→ Find more apps with this revenue gap · Full CalCs - Calendar Complications report
Side-by-side metrics
Bars scale to whichever app is bigger on that row. Green = winner.
vs
Monthly revenue (est.)?
$6
◀
$0
Annual revenue (est.)
$71
◀
$0
Lifetime installs (est.)
450
▶
9.9M
Monthly active users (est.)?
52.65
▶
1.2M
App Store rating
4.56★
▶
4.59★
Total ratings
9
▶
90K
US grossing rank
-
=
-
Cheapest monthly sub
No sub
=
No sub
IAP tiers detected
0 tiers
=
0 tiers
- Category
- Utilities
- Price
- USD0.49
- Released
- Apr 24, 2024
- Last updated
- Jun 29, 2026
- File size
- 5.1 MB
- Content rating
- 4+
- Version
- 1.109
- Languages
- English
- Category
- Utilities
- Price
- Free
- Released
- Oct 23, 2019
- Last updated
- Jun 8, 2026
- File size
- 163.8 MB
- Content rating
- 17+
- Version
- 3.5.7
- Languages
- Danish, Dutch, English, French, German, Italian +8 more
CalCs - Calendar Complications trajectory
Kemo Pro trajectory
FAQ
Which makes more money, CalCs - Calendar Complications or Kemo Pro? v
CalCs - Calendar Complications earns about $6 per month, while Kemo Pro earns about $0. That is a ∞× revenue gap (~$6 more per month for CalCs - Calendar Complications). Annual revenue: CalCs - Calendar Complications ≈ $71/year, Kemo Pro ≈ $0/year. Estimates are derived from public App Store signals - grossing rank, scraped IAP tiers, ratings and category benchmarks.
Which has more downloads, CalCs - Calendar Complications or Kemo Pro? v
Kemo Pro leads with about 9.9M estimated downloads vs 450 for CalCs - Calendar Complications - a 21995.6× gap. CalCs - Calendar Complications's App Store downloads are estimated from 9 ratings × the standard 1:75 ratio. Kemo Pro's App Store downloads are estimated from 90K ratings.
Are CalCs - Calendar Complications and Kemo Pro in the same App Store category and competing for the same money? v
Yes - both apps sit in the Utilities category, which means they compete directly for the same paying users and category-level wallet share. Direct competitors, head-to-head.
Do CalCs - Calendar Complications and Kemo Pro have in-app purchases? v
CalCs - Calendar Complications does not appear to offer in-app purchases on its public listing. Kemo Pro does not appear to offer in-app purchases. Monetization model: CalCs - Calendar Complications runs "Paid app ($0.49)", Kemo Pro runs "No App Store revenue (monetizes off-store)".
Which has better ratings, CalCs - Calendar Complications or Kemo Pro? v
Kemo Pro edges ahead with ★ 4.6 vs ★ 4.6 (gap of 0.0 stars). Rating volume: CalCs - Calendar Complications 9 ratings, Kemo Pro 90K ratings. Higher rating volume = stronger ASO signal even when star averages are close.
How accurate are these CalCs - Calendar Complications vs Kemo Pro revenue estimates? v
Directional - typically within 2-3× of actual money earned for popular apps. The $6 for CalCs - Calendar Complications and $0 for Kemo Pro are derived from App Store grossing rank, scraped IAP tiers, ratings volume and category benchmarks (Utilities) - net of the 15-30% Apple/Google store cut. Real revenue depends on country mix, retention, refunds and ad fill rate, none of which Apple or Google publish.
How do I compare CalCs - Calendar Complications or Kemo Pro to a different App Store app? v
Use the search box at the bottom of this page or paste any two App Store links into the homepage tool. We auto-generate a permanent comparison URL with revenue, downloads, IAP tiers, subscription pricing and grossing rank for both apps.
